Gary Zieziula
Direktor/Vorstandsmitglied bei INNOVENT BIOLOGICS, INC.
Vermögen: 23 851 $ am 30.04.2024
Aktive Positionen von Gary Zieziula
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| INNOVENT BIOLOGICS, INC. | Direktor/Vorstandsmitglied | 31.05.2022 | - |
| Independent Dir/Board Member | 31.05.2022 | - |
Karriereverlauf von Gary Zieziula
Ehemalige bekannte Positionen von Gary Zieziula
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Corporate Officer/Principal | 01.01.2014 | - |
| Präsident | - | 01.09.2018 | |
| AMAG PHARMACEUTICALS, INC. | Corporate Officer/Principal | 28.04.2010 | 04.11.2011 |
| MERCK & CO., INC. | Vertrieb & Marketing | - | - |
| BRISTOL-MYERS SQUIBB COMPANY | Vertrieb & Marketing | - | - |
Ausbildung von Gary Zieziula
| Canisius College | Masters Business Admin |
| State University of New York at Buffalo | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 7 |
| Cayman Islands | 2 |
Operativ
| Corporate Officer/Principal | 2 |
| Sales & Marketing | 2 |
| Masters Business Admin | 1 |
Sektoral
| Health Technology | 6 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| MERCK & CO., INC. | Health Technology |
| INNOVENT BIOLOGICS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
AMAG Pharmaceuticals, Inc.
 AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. Its products include Makena and Feraheme. It focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It also manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. The company was founded on November 9, 1981 and is headquartered in Waltham, MA. | Health Technology |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Health Technology |
- Börse
- Insiders
- Gary Zieziula
- Erfahrung
